IAMA Therapeutics
PrivateLast Round
Series B
Apr 16, 2025
Total Funding Raised
$25.83M
Company Overview
IAMA Therapeutics is a biotechnology company that develops a neuroscience drug discovery platform to provide personalized treatments for patients suffering from untreatable neurological conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
IAMA Therapeutics Comparables
Compare IAMA Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Axonis Therapeutics | 81% | |
| GRIK Therapeutics | 80% | |
| Actio Biosciences | 79% | |
IAMA Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 16, 2025 | ||||
| Series A | Mar 29, 2022 |
Key People
Founding team and executive leadership
IAMA Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Indaco Venture Partners SGR | Series B |
| Claris Ventures | Series A, Series B |
| Cassa Depositi e Prestiti | Series A, Series B |
| CDP Venture Capital SGR | Series B, Series A |
| ENEA-Tech and Biomedical Foundation | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 18, 2025
Torsten M. Madsen appointed as the new Chief Executive Officer.
- Sep 1, 2025
Torsten M. Madsen was dismissed in September 2025.
IAMA Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about IAMA Therapeutics's valuation, stock price, and market status.